Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD study of NTRX-07 in healthy volunteers
NCT04375436Phase 1Completed
- Sponsor
- NeuroTherapia, Inc.
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in neuropathic pain comparing NTRX-07 with Placebo (2 arms). Primary endpoints: Number of subjects with treatment emergent adverse events at 7 days, Number of subjects with Treatment related subjective effects at 7 days and 1 more. Started Oct 2019; status: completed.
02
Drugs
NTRX-07
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04375436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375436.